Kidney Cancer Conference Highlights from ASCO GU 2025

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates, focused on clear cell renal cell carcinoma (ccRCC), you need to know from GU ASCO 2025.

March 3, 2025

Dana-Farber

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Medical Oncology
- Genitourinary Oncology
- Translational Cancer Research
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Medical Oncology
- Genitourinary Oncology
- Cancer Immunotherapy
#3

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD
Key Differentiators
- Medical Oncology
- Genitourinary Oncology
- Molecular Oncology
#4

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Medical Oncology
- Genitourinary Oncology
- Clinical Trials
#5

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

San Francisco, CA
Key Differentiators
- Medical Oncology
- Genitourinary Oncology
- Immunotherapy Research

Kidney Cancer Conference Highlights from ASCO GU 2025

Top Institutions in Oncology

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

MD Anderson Cancer Center

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

Original Source(s)

Kidney Cancer Conference Highlights from ASCO GU 2025

Related Content

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities